|
KIF4A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.178000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.738300E-02 |
| Normal-vs-Stage2 |
9.176400E-01 |
| Normal-vs-Stage3 |
1.206750E-01 |
| Normal-vs-Stage4 |
2.452400E-02 |
| Stage1-vs-Stage2 |
1.617500E-03 |
| Stage1-vs-Stage3 |
8.689200E-01 |
| Stage1-vs-Stage4 |
1.669180E-01 |
| Stage2-vs-Stage3 |
1.303860E-02 |
| Stage2-vs-Stage4 |
2.278100E-03 |
| Stage3-vs-Stage4 |
2.131200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.204400E-02 |
| Normal-vs-AfricanAmerican |
2.496400E-01 |
| Normal-vs-Asian |
1.618970E-01 |
| Caucasian-vs-AfricanAmerican |
6.139800E-01 |
| Caucasian-vs-Asian |
5.683600E-01 |
| AfricanAmerican-vs-Asian |
9.338400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.764300E-02 |
| Normal-vs-Female |
1.173960E-01 |
| Male-vs-Female |
4.504000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.893700E-02 |
| Normal-vs-Age(41-60Yrs) |
5.832000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.404810E-01 |
| Normal-vs-Age(81-100Yrs) |
1.338370E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.91680000000738E-05 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.224400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.216600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.092200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.696400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.534650E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.748600E-01 |
| Classical-VS-Follicular |
4.31740000417236E-08 |
| Classical-VS-Other |
2.477000E-01 |
| Classical-VS-Normal |
2.707900E-02 |
| Tall-VS-Follicular |
2.097000E-03 |
| Tall-VS-Other |
1.869840E-01 |
| Tall-VS-Normal |
4.505700E-02 |
| Follicular-VS-Other |
6.363800E-01 |
| Follicular-VS-Normal |
6.390400E-01 |
| Other-VS-Normal |
9.419800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.049400E-01 |
| Normal-vs-N1 |
1.078180E-01 |
| N0-vs-N1 |
2.771200E-01 |
|
|
